A2315A (madumycin II)

Class: Virginiamycin

Institute where first reported:	Elli Lilly and Company.
Year first mentioned:	1974
Highest developmental phase:	Preclinical
Development status:	Inactive

Chemical structure(s):
Canonical SMILES:	CC(C)[C@@H]1[C@H](C)/C=C/C(=O)NC/C=C/C(=C/[C@H](C[C@@H](CC2=NC(=CO2)C(=O)N[C@H](C)C(=O)O1)O)O)/C
Isomeric SMILES:	C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](C[C@@H](CC2=NC(=CO2)C(=O)N[C@@H](C(=O)O[C@@H]1C(C)C)C)O)O)/C
InChI:	InChI=1S/C26H37N3O7/c1-15(2)24-17(4)8-9-22(32)27-10-6-7-16(3)11-19(30)12-20(31)13-23-29-21(14-35-23)25(33)28-18(5)26(34)36-24/h6-9,11,14-15,17-20,24,30-31H,10,12-13H2,1-5H3,(H,27,32)(H,28,33)/b7-6+,9-8+,16-11+/t17-,18-,19-,20+,24-/m1/s1
InChI Key:	SAQNYTQFLPVTNJ-WWUMGCNISA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/21596528

External links:
Guide to Pharmacology:	A2315A
Citation:	https://www.jstage.jst.go.jp/article/antibiotics1968/30/3/30_3_197/_article